Peripheral Artery Disease in Vastmanland

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

457 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-05-31

Study Completion Date

2011-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main purposes of this study are:

* to describe the prevalence and degree of reduced left ventricular function and hypertrophy in patients with peripheral arterial disease in comparison to controls from the general population,
* to evaluate factors of importance to left ventricular dysfunction and hypertrophy in patients with peripheral arterial disease, and
* to assess the impact of cardiac function and left ventricular hypertrophy on long-term prognosis in patients with peripheral artery disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Blood Factors and Peripheral Arterial Disease Outcomes

NCT00035776

Arterial Occlusive Diseases Cardiovascular Diseases Peripheral Vascular Diseases +1 more

COMPLETED

The Frequency of Peripheral Arterial Disease in Patients with Deep Vein Thrombosis of the Lower Limbs

NCT06806540

Thromboembolism Peripheral Arterial Disease

RECRUITING

Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies

NCT02959723

Idiopathic Pulmonary Arterial Hypertension

UNKNOWN

PAD Registry and Fitbit Sub-Study Program

NCT03446014

Peripheral Artery Disease

COMPLETED

Observational Study of Risk Factors for Peripheral Artery Disease in Bathroom Scale Withings Body Cardio Users

NCT07082517

PAD - Peripheral Arterial Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Left ventricular dysfunction is often a consequence of coronary heart disease (CHD). CHD is prevalent among patients with peripheral artery disease. However, there is limited data regarding left ventricular morphology and function in those patients. In the cross-sectional part of this study we will describe the prevalence of reduced cardiac function and left ventricular hypertrophy in a cohort of patients with peripheral artery disease. The patient outcomes will be compared to control subjects randomly selected from the general population in a case-control design. Further, clinical and genetic determinants of cardiac dysfunction in the patient cohort will be identified. In the longitudinal part of the study, the impact of cardiac function and morphology on cardiovascular mortality and morbidity will be evaluated in the cohort.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Vascular Diseases Heart Failure Ventricular Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Fulfillment of at least one of the following criteria:

* ankle-brachial-index (ABI) \<= 0.9, or
* stenosis of \> 30% of the internal carotid artery, or
* symptoms typical for claudication and corresponding stenotic findings on the ultrasound examination.